Skip to main content
Premium Trial:

Request an Annual Quote

What's It Worth?

Open Access News links to two articles that take different sides on the question of whether the open access movement is anti-publishing. At Scholarly Kitchen, Kent Anderson says it is. "The value proposition is that content is so worthless that you have to pay to have it published, and you can't charge for it even then," he writes. Kevin Smith responds at Scholarly Communications @ Duke that "the value of scholarly work, for scholars, has never been based on the money it could earn, since they never saw a penny of that money and were, in fact, expected to pay for access to their own writings."

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.